Assessing the validity of the Omron HEM-907XL oscillometric blood pressure measurement device in a National Survey environment

在全国调查环境下评估欧姆龙 HEM-907XL 示波法血压测量仪的有效性

阅读:1

Abstract

Blood pressure (BP) readings taken by Omron HEM-907XL were compared with the results obtained using sphygmomanometer (HgS) in 509 individuals using 2002 Association for the Advancement of Medical Instrumentation (AAMI) criteria. With the exception of diastolic BP in youth ages 13 to 19 years (mean difference, -1.77 mm Hg; standard deviation, 8.65), the Omron device met the criteria. Agreement for hypertension (BP >or=140/90 mm Hg) was above chance (kappa=0.68) and, compared with HgS, Omron underestimated the prevalence of hypertension by 2.65%. The Omron and HgS measurements were highly correlated (r=0.94 for systolic BP and r=0.83 for diastolic BP). Both increased systolic and diastolic BP decreased device agreement (beta-coefficient=-0.10872, P<.0001; beta-coefficient=-0.25981, P<.0001, respectively). The Omron device meets AAMI criteria with the exception of diastolic BP in youth ages 13 to 19 years. However, Omron underestimated the prevalence of hypertension and device agreement decreases with increased systolic and diastolic BP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。